Get Premium to unlock powerful stock data
NYSE:ABT (USA)  
Abbott Laboratories logo

Abbott Laboratories

$ 109.30 -0.92 (-0.83%) 10:08 PM EST
P/E:
25.36
P/B:
5.41
Market Cap:
$ 191.38B
Enterprise V:
$ 200.31B
Volume:
4.75M
Avg Vol (2M):
5.64M
Also Trade In:
Volume:
4.75M
Market Cap $:
191.38B
PE Ratio:
25.36
Avg Vol (2-Month):
5.64M
Enterprise Value $:
200.31B
PB Ratio:
5.41
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Financials (Next Earnings Date:2022-07-20)

ABT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:ABT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 44,514
EPS (TTM) ($) 4.31
Beta 0.75
Volatility % 23.8
14-Day RSI 49.37
14-Day ATR ($) 2.852419
20-Day SMA ($) 108.3705
12-1 Month Momentum % -1.25
52-Week Range ($) 101.24 - 142.6
Shares Outstanding (Mil) 1,750.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abbott Laboratories Filings

Document Form Filing Date
No Filing Data

Headlines

See More